vanadates has been researched along with amsacrine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, K; Kume, T; Oishi, M; Shiraishi, T; Tsuneizumi, K; Watanabe, T | 1 |
| Biersack, H; Boege, F; Clark, M; Gieseler, F | 1 |
| Biersack, H; Boege, F; Meyer, P | 1 |
| Biersack, H; Boege, F; Gieseler, F; Meyer, P | 1 |
4 other study(ies) available for vanadates and amsacrine
| Article | Year |
|---|---|
Synergistic induction of erythroid differentiation of mouse erythroleukemia (MEL) cells by inhibitors of topoisomerases and protein tyrosine kinases.
Topics: Acetamides; Amsacrine; Animals; Blotting, Western; Camptothecin; Cell Differentiation; Cinnamates; Dimethyl Sulfoxide; Hemoglobins; Leukemia, Erythroblastic, Acute; Mice; Mitomycin; Protein-Tyrosine Kinases; Sulfides; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vanadates | 1992 |
Use of anion-exchange chromatography and chromatofocusing to reveal the structural and functional heterogeneity of topoisomerase II in a HL-60 cell line resistant to multi-drug treatment.
Topics: Amsacrine; Catalysis; Cell Line; Chromatography, Ion Exchange; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Humans; Protein Conformation; Structure-Activity Relationship; Vanadates | 1991 |
Drug-sensitivity and DNA-binding of a subform of topoisomerase II alpha in resistant human HL-60 cells.
Topics: Amsacrine; Antigens, Neoplasm; Antineoplastic Agents; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Drug Resistance; Etoposide; Humans; Isoenzymes; Leukemia; Tumor Cells, Cultured; Vanadates | 1994 |
Different functional states of topoisomerase II can be discriminated by orthovanadate sensitivity in multi-drug resistant human leukemic cells.
Topics: Adenosine Triphosphate; Allosteric Site; Amsacrine; Chromatography, Ion Exchange; Clone Cells; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Humans; Isoenzymes; Leukemia, Promyelocytic, Acute; Molecular Weight; Neoplasm Proteins; Neoplastic Stem Cells; Point Mutation; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vanadates | 1993 |